Should You Add Ginkgo Bioworks Holdings Inc (DNA) Stock to Your Portfolio Monday? – InvestorsObserver


Ginkgo Bioworks Holdings Inc (DNA) is near the middle in its sector according to InvestorsObserver. DNA gets an overall rating of 30. That means it scores higher than 30% of stocks. Ginkgo Bioworks Holdings Inc gets a 51 rank in the Healthcare sector. Healthcare is number 4 out of 11 sectors.

DNA has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on DNA!

See Full DNA Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What’s Happening With Ginkgo Bioworks Holdings Inc Stock Today?

Ginkgo Bioworks Holdings Inc (DNA) stock is trading at $1.87 as of 11:48 AM on Monday, Jan 30, a loss of -$0.09, or -4.36% from the previous closing price of $1.95. The stock has traded between $1.82 and $1.95 so far today. Volume today is below average. So far 9,630,771 shares have traded compared to average volume of 21,069,432 shares. Click Here to get the full Stock Report for Ginkgo Bioworks Holdings Inc stock.